AIOS International Webinar on Ocular Oncology - What New am I Doing in 2020

Topic - Protocol-based Management of Sebaceous Gland Carcinoma
Speaker-Dr Fairooz PM

.

Chapters

0:00 Introduction/Constant Bloating
0:43 Pelvis or lower abdomen pain
1:42 Eating Issues
2:41 Urgent need to urinate



Ovarian cancer is a cancer that forms in or on an ovary.[4][9] It results in abnormal cells that have the ability to invade or spread to other parts of the body.[10] When this process begins, there may be no or only vague symptoms.[1] Symptoms become more noticeable as the cancer progresses.[1][11] These symptoms may include bloating, pelvic pain, abdominal swelling, constipation, and loss of appetite, among others.[1] Common areas to which the cancer may spread include the lining of the abdomen, lymph nodes, lungs, and liver.[12]

The risk of ovarian cancer increases in women who have ovulated more over their lifetime. This includes those who have never had children, those who begin ovulation at a younger age and those who reach menopause at an older age.[3] Other risk factors include hormone therapy after menopause, fertility medication, and obesity.[4][5] Factors that decrease risk include hormonal birth control, tubal ligation, and breast feeding.[5] About 10% of cases are related to inherited genetic risk; women with mutations in the genes BRCA1 or BRCA2 have about a 50% chance of developing the disease.[3] Ovarian carcinoma is the most common type of ovarian cancer, comprising more than 95% of cases.[3] There are five main subtypes of ovarian carcinoma, of which high-grade serous carcinoma (HGSC) is the most common.[3] These ovarian tumors are believed to start in the cells covering the ovaries,[3] though some may form at the Fallopian tubes.[13] Less common types of ovarian cancer include germ cell tumors[14] and sex cord stromal tumors.[3] A diagnosis of ovarian cancer is confirmed through a biopsy of tissue, usually removed during surgery.[1]

Screening is not recommended in women who are at average risk, as evidence does not support a reduction in death and the high rate of false positive tests may lead to unneeded surgery, which is accompanied by its own risks.[15] Those at very high risk may have their ovaries removed as a preventive measure.[4] If caught and treated in an early stage, ovarian cancer is often curable.[1] Treatment usually includes some combination of surgery, radiation therapy, and chemotherapy.[1] Outcomes depend on the extent of the disease, the subtype of cancer present, and other medical conditions.[16][3] The overall five-year survival rate in the United States is 49%.[6] Outcomes are worse in the developing world.[3]

In 2012, new cases occurred in approximately 239,000 women.[3] In 2015 it was present in 1.2 million women and resulted in 161,100 deaths worldwide.[8][7] Among women it is the seventh-most common cancer and the eighth-most common cause of death from cancer.[3] The typical age of diagnosis is 63.[2] Death from ovarian cancer is more common in North America and Europe than in Africa and Asia.[3]

S****ey discusses her journey with low grade mucinous neoplasm of the appendix and the positive impact of the St. John Providence HIPEC program on her life.

Intervento del Prof. Umberto Gianelli (MPN progression) e della Prof.ssa Elena Sabattini (Mastocytosis) al primo evento virtuale di digital pathology rivolto ai Patologi afferenti ai Centri di Ematologia italiani – 16 settembre 2020

In this video I will show you another old male patient with very later presentation and involvement of inferior orbital structures with superior displacement of eyeball

Through complex lung-sparing surgery and an innovative approach to follow-up care, UCLA’s Comprehensive Mesothelioma Program is improving the longevity and quality of life of patients with mesothelioma, a rare and difficult-to-treat cancer that has long been associated with a poor prognosis.

Read more at ucla.in/1ERrdJ1

Dr Hrushikesh Kharosekar
Dr Vernon Velho
JJNSx

Dr. Houssam Osman
HPB & foregut surgeon
Associate director, HPB fellowship, Methodist Richardson Medical Center
Dallas, Texas, USA.
#Sudanese_Surgical_Club

Mrs. Shelina Akhter from Bangladesh suffered from reduced hearing and pulsatile tinnitus in the left ear for 3 years. She consulted team BSBI and was diagnosed to have left tympanomastoid paraganglioma.

She underwent Intact Canal Wall Mastoidectomy with Canalplasty with Tympanoplasty (type 2). The tumor was excised completely and hearing
was restored. She is currently disease-free and on regular follow-up.